These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16459665)

  • 1. [Follow-up of urothelial tumours. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
    Irani J; Lebret T; Theodore C; Davin JL;
    Prog Urol; 2005 Sep; 15(4):581-6. PubMed ID: 16459665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow-up of renal cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
    Fendler JP; Patard JJ; Mejean A; Davin JL;
    Prog Urol; 2005 Sep; 15(4):577-81. PubMed ID: 16459664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follow-up of testicular germ cell tumours. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
    Culine S; Michel F; Rocher L; Mottet N; Davin JL;
    Prog Urol; 2005 Sep; 15(4):593-6. PubMed ID: 16459667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up of malignant tumours of the penis. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
    Bastide C; Iborra F; Mottet N; Davin JL;
    Prog Urol; 2005 Sep; 15(4):596-7. PubMed ID: 16459668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Follow-up of prostate cancer. Guidelines of the Comité de Cancérologie de l'Association Française d'Urologie].
    Richaud P; Moreau JL; Beuzeboc P; Rébillard X; Villers A; Peyromaure M; Cornud F; Soulié M; Davin JL;
    Prog Urol; 2005 Sep; 15(4):586-92. PubMed ID: 16459666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for reforming prostatic specimens. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie].
    Molinié V; Vieillefond A; Cochand-Priollet B; Dauge-Geffroy MC; Lefrère-Belda MA; de Fromont M; Lesourd A; Toublanc M; Berger N; Bouvier R; Villers A
    Ann Pathol; 1999 Dec; 19(6):549-56. PubMed ID: 10617819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.
    Oosterlinck W; Solsona E; Akaza H; Busch C; Goebell PJ; Malmström PU; Ozen H; Sved P
    Urology; 2005 Dec; 66(6 Suppl 1):75-89. PubMed ID: 16399417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comité de cancérologie de l'Association française d'urologie (CCAFU)].
    Neuzillet Y; Long JA; Paparel P; Baumert H; Correas JM; Escudier B; Lang H; Poissonnier L; Rioux-Leclercq N; Salomon L; Soulie M; Patard JJ;
    Prog Urol; 2009 Sep; 19(8):524-9. PubMed ID: 19699449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of the guidelines for the treatment of non-neurological urinary incontinence in women].
    Hermieu JF; Conquy S; Leriche B; Debodinance P; Delorme E; Boccon Gibod L; Cortesse A; Vidart A; Cour F; Richard F; Cardot V; Berlizot P; Lenormand L; Ragni E; Peyrat L; Yiou R; Ballanger P;
    Prog Urol; 2010 Feb; 20 Suppl 2():S94-9. PubMed ID: 20403574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
    Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
    Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
    Josephson DY; Pasin E; Stein JP
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
    Schmidbauer J; Lindenau G
    Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
    Gupta A; Lotan Y; Bastian PJ; Palapattu GS; Karakiewicz PI; Raj GV; Schoenberg MP; Lerner SP; Sagalowsky AI; Shariat SF;
    Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C.
    Soler-Martínez J; Vozmediano-Chicharro R; Morales-Jiménez P; Hernández-Alcaraz D; Vivas-Vargas E; Santos García-Vaquero I; Baena-González V
    J Urol; 2007 Dec; 178(6):2337-9. PubMed ID: 17936805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.